251 related articles for article (PubMed ID: 22119801)
1. Carbon monoxide induces a late preconditioning-mimetic cardioprotective and antiapoptotic milieu in the myocardium.
Stein AB; Bolli R; Dawn B; Sanganalmath SK; Zhu Y; Wang OL; Guo Y; Motterlini R; Xuan YT
J Mol Cell Cardiol; 2012 Jan; 52(1):228-36. PubMed ID: 22119801
[TBL] [Abstract][Full Text] [Related]
2. Administration of a CO-releasing molecule induces late preconditioning against myocardial infarction.
Stein AB; Guo Y; Tan W; Wu WJ; Zhu X; Li Q; Luo C; Dawn B; Johnson TR; Motterlini R; Bolli R
J Mol Cell Cardiol; 2005 Jan; 38(1):127-34. PubMed ID: 15623429
[TBL] [Abstract][Full Text] [Related]
3. Beneficial effects of carbon monoxide-releasing molecules on post-ischemic myocardial recovery.
Varadi J; Lekli I; Juhasz B; Bacskay I; Szabo G; Gesztelyi R; Szendrei L; Varga E; Bak I; Foresti R; Motterlini R; Tosaki A
Life Sci; 2007 Apr; 80(17):1619-26. PubMed ID: 17321552
[TBL] [Abstract][Full Text] [Related]
4. Cardioprotective actions by a water-soluble carbon monoxide-releasing molecule.
Clark JE; Naughton P; Shurey S; Green CJ; Johnson TR; Mann BE; Foresti R; Motterlini R
Circ Res; 2003 Jul; 93(2):e2-8. PubMed ID: 12842916
[TBL] [Abstract][Full Text] [Related]
5. Carbon Monoxide (CO) Released from Tricarbonyldichlororuthenium (II) Dimer (CORM-2) in Gastroprotection against Experimental Ethanol-Induced Gastric Damage.
Magierowska K; Magierowski M; Hubalewska-Mazgaj M; Adamski J; Surmiak M; Sliwowski Z; Kwiecien S; Brzozowski T
PLoS One; 2015; 10(10):e0140493. PubMed ID: 26460608
[TBL] [Abstract][Full Text] [Related]
6. Cardioprotective and antiapoptotic effects of heme oxygenase-1 in the failing heart.
Wang G; Hamid T; Keith RJ; Zhou G; Partridge CR; Xiang X; Kingery JR; Lewis RK; Li Q; Rokosh DG; Ford R; Spinale FG; Riggs DW; Srivastava S; Bhatnagar A; Bolli R; Prabhu SD
Circulation; 2010 May; 121(17):1912-25. PubMed ID: 20404253
[TBL] [Abstract][Full Text] [Related]
7. Acute myocardial infarction in streptozotocin-induced hyperglycaemic rats: protection by a carbon monoxide-releasing molecule (CORM-3).
Filippo CD; Perretti M; Rossi F; Ferraraccio F; Motterlini R; D'Amico M
Naunyn Schmiedebergs Arch Pharmacol; 2012 Feb; 385(2):137-44. PubMed ID: 22038495
[TBL] [Abstract][Full Text] [Related]
8. IL-6 plays an obligatory role in late preconditioning via JAK-STAT signaling and upregulation of iNOS and COX-2.
Dawn B; Xuan YT; Guo Y; Rezazadeh A; Stein AB; Hunt G; Wu WJ; Tan W; Bolli R
Cardiovasc Res; 2004 Oct; 64(1):61-71. PubMed ID: 15364614
[TBL] [Abstract][Full Text] [Related]
9. CORM-2 inhibits intracerebral hemorrhage-mediated inflammation.
Chen Z; Zhang H; Zhou J; Stone C; Ding Y; Zhang Y; Ren C; Yin X; Meng R
Neurol Res; 2021 Oct; 43(10):846-853. PubMed ID: 34107862
[No Abstract] [Full Text] [Related]
10. Endothelial nitric oxide synthase plays an obligatory role in the late phase of ischemic preconditioning by activating the protein kinase C epsilon p44/42 mitogen-activated protein kinase pSer-signal transducers and activators of transcription1/3 pathway.
Xuan YT; Guo Y; Zhu Y; Wang OL; Rokosh G; Bolli R
Circulation; 2007 Jul; 116(5):535-44. PubMed ID: 17606840
[TBL] [Abstract][Full Text] [Related]
11. Evaluating the effects of carbon monoxide releasing molecule-2 against myocardial ischemia-reperfusion injury in ovariectomized female rats.
Kumar A; Boovarahan SR; Prem PN; Ramanathan M; Chellappan DR; Kurian GA
Naunyn Schmiedebergs Arch Pharmacol; 2021 Oct; 394(10):2103-2115. PubMed ID: 34338837
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological preconditioning with phosphodiestrase inhibitor: an answer to stem cell survival against ischemic injury through JAK/STAT signaling.
Yadav M; Kumari P; Yadav V; Kumar S
Heart Fail Rev; 2020 Mar; 25(2):355-366. PubMed ID: 31309353
[TBL] [Abstract][Full Text] [Related]
13. Nrf2/HO-1 partially regulates cytoprotective effects of carbon monoxide against urban particulate matter-induced inflammatory responses in oral keratinocytes.
Cheng CY; Vo TTT; Lin WN; Huang HW; Chuang CC; Chu PM; Lee IT
Cytokine; 2020 Sep; 133():155185. PubMed ID: 32615411
[TBL] [Abstract][Full Text] [Related]
14. Hydrogen sulfide mediates cardioprotection through Nrf2 signaling.
Calvert JW; Jha S; Gundewar S; Elrod JW; Ramachandran A; Pattillo CB; Kevil CG; Lefer DJ
Circ Res; 2009 Aug; 105(4):365-74. PubMed ID: 19608979
[TBL] [Abstract][Full Text] [Related]
15. Cardioprotective effect with carbon monoxide releasing molecule-2 (CORM-2) in isolated perfused rat heart: Role of coronary endothelium and underlying mechanism.
Soni H; Patel P; Rath AC; Jain M; Mehta AA
Vascul Pharmacol; 2010; 53(1-2):68-76. PubMed ID: 20399902
[TBL] [Abstract][Full Text] [Related]
16. Carbon monoxide releasing molecule‑2 attenuated ischemia/reperfusion‑induced apoptosis in cardiomyocytes via a mitochondrial pathway.
Zhao S; Lin Q; Li H; He Y; Fang X; Chen F; Chen C; Huang Z
Mol Med Rep; 2014 Feb; 9(2):754-62. PubMed ID: 24337106
[TBL] [Abstract][Full Text] [Related]
17. The carbon monoxide releasing molecule (CORM-3) inhibits expression of vascular cell adhesion molecule-1 and E-selectin independently of haem oxygenase-1 expression.
Song H; Bergstrasser C; Rafat N; Höger S; Schmidt M; Endres N; Goebeler M; Hillebrands JL; Brigelius-Flohé R; Banning A; Beck G; Loesel R; Yard BA
Br J Pharmacol; 2009 Jul; 157(5):769-80. PubMed ID: 19422386
[TBL] [Abstract][Full Text] [Related]
18. Carbon monoxide-releasing molecule-2 (CORM-2) attenuates acute hepatic ischemia reperfusion injury in rats.
Wei Y; Chen P; de Bruyn M; Zhang W; Bremer E; Helfrich W
BMC Gastroenterol; 2010 May; 10():42. PubMed ID: 20444253
[TBL] [Abstract][Full Text] [Related]
19. Coronary effluent from a preconditioned heart activates the JAK-STAT pathway and induces cardioprotection in a donor heart.
Huffman LC; Koch SE; Butler KL
Am J Physiol Heart Circ Physiol; 2008 Jan; 294(1):H257-62. PubMed ID: 17982005
[TBL] [Abstract][Full Text] [Related]
20. The CO-releasing molecule CORM-3 protects adult cardiomyocytes against hypoxia-reoxygenation by modulating pH restoration.
Portal L; Morin D; Motterlini R; Ghaleh B; Pons S
Eur J Pharmacol; 2019 Nov; 862():172636. PubMed ID: 31491405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
